TAK1 blockade as a therapy for retinal neovascularization.
Wang JH, Lin FL, Chen J, Zhu L, Chuang YF, Tu L, Ma C, Ling D, Hewitt AW, Tseng CL, Shah MH, Bui BV, van Wijngaarden P, Dusting GJ, Wang PY, Liu GS.
Wang JH, et al. Among authors: lin fl.
Pharmacol Res. 2023 Jan;187:106617. doi: 10.1016/j.phrs.2022.106617. Epub 2022 Dec 16.
Pharmacol Res. 2023.
PMID: 36535572
Free article.